Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Schering-Plough Announces Phase II And III Data For Corifollitropin Alfa
Schering-Plough Corp., (NYSE: SGP) announced results from the Phase III ENGAGE clinical trial demonstrating that a single injection of corifollitropin alfa, first in the class of sustained follicle stimulants, achieved similar efficacy to recombinant follicle stimulating hormone (rFSH) given once daily for seven days. The ENGAGE data was presented along with data from the Phase III ENSURE trial and the Phase II REALIZE trial at the 25th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) in Amsterdam, The Netherlands.
generic viagra online
Prostate Cancer Screening And Trust Of Physician Evaluated
Trusted health care s and continuity of care may help reduce the risk of prostate cancer deaths in African-American men, according to a study published in the current issue of the journal Cancer. James Mohler, MD, Chair of the Department of Urology at Roswell Park Cancer Institute (RPCI), and William R. Carpenter, PhD, Department of Health Policy and Management at the University of North Carolina, are lead investigators.
News of the day
Illinois Public Health Director Presents At H1N1 Flu Preparedness Summit To Further Prepare For Possibility Of More Severe H1N1 Outbreak In The Fall
Speaking at a national summit this week on H1N1 flu preparedness, Dr. Damon T. Arnold, state public health director, stressed the need to prepare for the possibility the fall flu season could be more severe than normal.
Mental Health

Announcing National MS And Parkinson's Disease Registries Act

Senator Byron Dorgan (ND) on Tuesday introduced legislation that would for the first time establish a national coordinated system to collect and analyze data on multiple sclerosis and Parkinson"s disease. Accurate incidence and prevalence information on these two diseases currently does not exist. Click here to ask your Senator to support this legislation. The National MS and Parkinson"s Disease Registries Act would establish separate registries for MS and Parkinson"s disease at the Agency for Toxic Substances and Disease Registry at the Centers for Disease Control and Prevention (CDC). The National Multiple Sclerosis Society has worked closely with the Parkinson"s Action Network to introduce legislation in both chambers of Congress to address the lack of accurate incidence information that both communities face. Both organizations will be advocating to advance this legislation and have it signed into law in the 111th Congress. "I often receive letters from people living with MS who are concerned about whether the current numbers accurately reflect the MS community," National MS Society President and CEO Joyce Nelson said. "A national multiple sclerosis registry will give us a clearer picture of the impact of MS and help us better serve all those who live with this disease." Lack of core information and knowledge about who has MS and Parkinson"s disease inhibits progress in biomedical research, the development of new and better treatments, and the creation of programs and services to help people live independent and productive lives while fighting these diseases. These registries will authorize the CDC to develop national coordinated systems to collect and analyze existing MS and Parkinson"s disease data. The epidemiological data collected and analyzed through the registries will provide a foundation for better evaluating and understanding issues such as geographic clusters of diagnosis, genetic and environmental risk factors, variances in gender ratio, disease burden, and changes in health care practices. This important legislation also sets the ground work for developing epidemiological registries for other neurological diseases and disorders. National MS Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009